Pharma businesses all along the supply chain, from research materials to drug manufacturing and sales, have achieved comfortable profits by holding fast to high quality and safety standards.

The US Inflation Reduction Act of 2022 sets forth demand and supply-side incentives to encourage solar manufacturing within the United States in the form of production tax credits for ...